Postoperative perianal abscess or anal fistula
Conditions
Interventions
control group:Basic treatment
Experimental Group 2:Basic treatment+compound Huangbai liquid coating 20ml rinse
Experimental Group 1:Basic treatment+intracavitary placement and wet compress of compound Huangbai liquid coating
Sponsors
First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed clinically with low perianal abscess or low simple anal fistula who require or are planned to undergo surgical treatment on the day of enrollment; 2. Gender is not limited age range is 18-60 years old (including threshold values); 3. The subjects are informed voluntarily sign the informed consent form and agree to participate in all visits examinations and treatments according to the requirements of the trial protocol.
Exclusion criteria
Exclusion criteria: 1. Patients with other infectious diseases systemic diseases or abnormal immune function who need antibiotic treatment; 2. Patients diagnosed with high anal fistula complex anal fistula complex perianal abscess abscess above the levator ani muscle horseshoe shaped abscess and female anterior abscess; 3. Patients with hemorrhoids who require surgical treatment; 4. Patients with colorectal tumor lesions; 5. Patients with cellulitis artificial heart valves congenital heart disease heart valve transplantation and diabetes; 6. Perianal abscess accompanied by HIV and tuberculosis infection; 7. Patients with ulcerative colitis and Crohn's disease; 8. Pregnant and lactating women as well as during the trial period should not strictly use contraception; 9. Allergic to the components of the experimental drug; 10. Participated in other clinical trials within the past 3 months; 11. The researchers believe that it is not appropriate to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decay removal time: from the date of the first dressing change to the time when purulent discharge and pus coating disappear (defined as the color of the granulation tissue on the wound turning bright red, with no purulent discharge and/or pus coating on the surface, and no purulent discharge from the replaced dressing); | — |
Secondary
| Measure | Time frame |
|---|---|
| Time of appearance of new epithelium: observe the earliest days of appearance of new epithelial tissue after self use of medication;Visit 2, Visit 3, Visit 4, Visit 5 Purulent Secretion Score (Score and photo retention for each visit);Visit 2, Visit 3, Visit 4, Visit 5 granulation tissue morphology score (score and take photos for each visit);Visit 2, Visit 3, Visit 4, Visit 5 wound reduction rate (score and take photos for each visit); | — |
Countries
China
Contacts
Public ContactWeimin Luo
First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Outcome results
None listed